Charles Schwab
GBT

Charles Schwab’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Charles Schwab’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-480,794
Closed -$32.7M – 3621
2022
Q3 		$32.7M Buy
480,794
+47,651
+11% +$2.63M 0.01% 1036
2022
Q2 		$13.8M Sell
433,143
-2,357
-0.5% -$69K ﹤0.01% 1645
2022
Q1 		$15.1M Buy
435,500
+13,793
+3% +$412K ﹤0.01% 1728
2021
Q4 		$12.3M Buy
421,707
+20,030
+5% +$620K ﹤0.01% 1889
2021
Q3 		$10.2M Sell
401,677
-22,378
-5% -$658K ﹤0.01% 1997
2021
Q2 		$14.9M Buy
424,055
+127,104
+43% +$4.96M ﹤0.01% 1778
2021
Q1 		$12.1M Sell
296,951
-18,412
-6% -$846K ﹤0.01% 1845
2020
Q4 		$13.7M Buy
315,363
+4,717
+2% +$233K 0.01% 1667
2020
Q3 		$17.1M Buy
310,646
+957
+0.3% +$60.8K 0.01% 1308
2020
Q2 		$19.6M Sell
309,689
-93,219
-23% -$6.39M 0.01% 1193
2020
Q1 		$20.6M Buy
402,908
+27,813
+7% +$1.86M 0.01% 993
2019
Q4 		$29.8M Buy
375,095
+8,502
+2% +$504K 0.02% 942
2019
Q3 		$17.8M Buy
366,593
+41,228
+13% +$2.15M 0.01% 1225
2019
Q2 		$17.1M Buy
325,365
+11,148
+4% +$641K 0.01% 1246
2019
Q1 		$16.6M Buy
314,217
+19,493
+7% +$958K 0.01% 1227
2018
Q4 		$12.1M Buy
294,724
+13,868
+5% +$520K 0.01% 1336
2018
Q3 		$10.7M Buy
280,856
+22,713
+9% +$1.01M 0.01% 1592
2018
Q2 		$11.7M Buy
258,143
+45,038
+21% +$2.05M 0.01% 1488
2018
Q1 		$10.3M Buy
213,105
+36,661
+21% +$2.04M 0.01% 1472
2017
Q4 		$6.94M Buy
176,444
+22,325
+14% +$834K 0.01% 1733
2017
Q3 		$4.79M Buy
154,119
+4,485
+3% +$126K ﹤0.01% 1895
2017
Q2 		$4.09M Buy
149,634
+38,829
+35% +$1.16M ﹤0.01% 1925
2017
Q1 		$4.08M Buy
110,805
+44,383
+67% +$1.12M ﹤0.01% 1872
2016
Q4 		$960K Buy
66,422
+3,696
+6% +$64.9K ﹤0.01% 2441
2016
Q3 		$1.45M Buy
62,726
+30,436
+94% +$580K ﹤0.01% 2285
2016
Q2 		$536K Buy
32,290
+12,536
+63% +$253K ﹤0.01% 2565
2016
Q1 		$314K Buy
19,754
+408
+2% +$7.25K ﹤0.01% 2755
2015
Q4 		$626K Buy
19,346
+13,306
+220% +$576K ﹤0.01% 2544
2015
Q3 		$255K Buy
+6,040
New +$285K ﹤0.01% 2887

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Charles Schwab's GBT Position: Q4 2022 in Review

Charles Schwab sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 480,794 shares — an estimated $32.7M sold.

Charles Schwab first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $32.7M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Charles Schwab reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Charles Schwab sold 480,794 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $32.7M.
  • Charles Schwab first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
  • Charles Schwab's Global Blood Therapeutics, Inc. position peaked at $32.7M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.